Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart Cart lightblue
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Location


Corporate Headquarters

Vector Laboratories, Inc.
6737 Mowry Ave
Newark, CA 94560
United States

Telephone Numbers



Customer Service: (800) 227-6666 / (650) 697-3600


Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-C188622-0.1 0.1 mg (0.1 mg/ml) $556 
Antibody

Monoclonal Mouse anti‑Human APOE / Apolipoprotein E Antibody (clone WUE‑4, Biotin, WB) LS‑C188622

Monoclonal Mouse anti‑Human APOE / Apolipoprotein E Antibody (clone WUE‑4, Biotin, WB) LS‑C188622

Antibody:
APOE / Apolipoprotein E Mouse anti-Human Monoclonal (Biotin) (WUE-4) Antibody
Application:
WB, ELISA
Reactivity:
Human
Format:
Biotin, Unmodified
Other formats:
Price
Catalog Number
$556
LS-C188622-0.1
Toll Free North America
(800) 227-6666
For Research Use Only

Overview

Antibody:
APOE / Apolipoprotein E Mouse anti-Human Monoclonal (Biotin) (WUE-4) Antibody
Application:
WB, ELISA
Reactivity:
Human
Format:
Biotin, Unmodified
Other formats:

Specifications

Description
Apolipoprotein E antibody LS-C188622 is a biotin-conjugated mouse monoclonal antibody to human Apolipoprotein E (APOE). Validated for ELISA and WB.
Target
Human APOE / Apolipoprotein E
Synonyms
APOE | AD2 | Apo-E | Apolipoprotein E3 | Apolipoprotein E | LDLCQ5 | LPG
Host
Mouse
Reactivity
Human (tested or 100% immunogen sequence identity)
Clonality
IgG1 Monoclonal
Clone
WUE-4
Conjugations
Biotin. Also available Unconjugated.
Purification
Protein G purified
Modifications
Unmodified
Immunogen
Purified ApoHDL fraction.
Specificity
Recognizes an epitope within amino acids 140-160 of human apolipoprotein E (Apo-E), a major component of very low-density lipoproteins (VLDLs). Apo-E is the principle apolipoprotein in the central nervous system, and is secreted by most organs into the plasma, playing a vital role in the binding, internalization and catabolism of triglyceride-rich lipoprotein constituents. Apo-E acts as a ligand for both the specific apo-E receptor (chylomicron remnant) of hepatic tissues, and the apoB, E (LDL) receptor. Three isoforms of Apo-E have been identified, ApoE2, E3 and E4, and have been linked with various disorders. ApoE2 has been shown to bind LPL receptors with low affinity, resulting in increased plasma cholesterol and triglyceride levels, and thereby an increased risk in cardiovascular disorders. ApoE4 is a known high risk factor for Alzheimer's disease, and in particular late onset Alzheimer disease 2 (AD2), whilst ApoE3 is the most common isoform, and considered the normal/natural Apo-E genotype. Clone 6-4 has been shown to inhibit Apo-E mediated binding of lipoproteins to the apoB, E cell receptor.
Applications
  • Western blot
  • ELISA
  • Applications tested for the base form of this product only
Usage
The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested.
Presentation
PBS, 0.09% Sodium Azide, 1% BSA
Storage
Store at 4°C or at -20°C. Store undiluted. Avoid freeze-thaw cycles. Microcentrifugation recommended if solution contains precipitate.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About APOE / Apolipoprotein E
P02649 NM_000041 NP_000032.1

Publications (0)

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 12/26/2024